Literature DB >> 19603228

Effects of obesity surgery on type 2 diabetes mellitus Asian patients.

Wei-Jei Lee1, Keong Chong, Yi-Chih Lee, Kong-Han Ser, Shu-Chun Chen, Jung-Chien Chen, Wei-Pang Peng, Chih-Ming Chen.   

Abstract

BACKGROUND: Obesity is a major risk factor for the development of type 2 diabetes mellitus (T2DM). Surgery is the most effective treatment for morbid obesity, and it has been shown to lead to dramatic improvement in type T2DM. However, data concerning obese Asian patients have not been reported, and the mechanism of improving T2DM after bariatric surgery in this population remains speculative.
METHODS: From April 1997 to March 2006, 1,375 patients undergoing obesity surgery were recruited for our study of the effects of weight loss surgery on type 2 diabetes mellitus (T2DM). Laparoscopic vertical banded gastric partition (LVBG) was performed in 552 patients (40.1%), laparoscopic gastric bypass in 660 patients (48.0%), and laparoscopic adjustable gastric banding (LAGB) in 140 patients (10.2%). Another 23 patients (1.7%) received open or revision surgery. We evaluated the clinical data and effect of obesity surgery on T2DM, impaired fasting glucose (IFG) and compared the changes with those with normal fasting glucose.
RESULTS: Among all the patients, 166 (12.1%) had impaired fasting glucose (IFG) and 247 (18.0%) had T2DM. Patients with IFG or DM were significantly older, more central obese, and they had higher insulin resistance and a higher HbA1C level than those with normal fasting glucose. The mean total weight loss for the population was 28.6%, 29.1%, 28.5%, 23.8%, and 24.4% (at 1, 2, 3, 5, and 7 years after surgery). There was no increase of surgical risk in T2DM or IFG patients. One year after operation, fasting plasma glucose returned to normal in 78.5% of T2DM patients and 94.7% of IFG patients. The HbA1C level returned to under 7.0 in 81.5% of T2DM and in 100% of IFG patients. Laparoscopic gastric bypass patients had a greater weight loss and a higher rate of glucose normalization (93.1%) than the LVBG patients (85.3%) and LAGB patients (73.9%), but no difference in HbA1C normalization.
CONCLUSIONS: Obesity surgery resulted in significant and sustained weight loss with a cure rate of T2DM up to 80% in morbidly obese Asian patients. Gastric bypass surgery had a better result in T2DM cure rate than LVBG and LAGB because of better weight reduction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19603228     DOI: 10.1007/s00268-009-0115-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  41 in total

1.  Effect of intensive dietetic interventions on weight and glycaemic control in overweight men with Type II diabetes: a randomised trial.

Authors:  S Ash; M M Reeves; S Yeo; G Morrison; D Carey; S Capra
Journal:  Int J Obes Relat Metab Disord       Date:  2003-07

2.  Short-term results of laparoscopic mini-gastric bypass.

Authors:  Weu Wang; Po-Li Wei; Yi-Chih Lee; Ming-Te Huang; Chong-Chi Chiu; Wei-Jei Lee
Journal:  Obes Surg       Date:  2005-05       Impact factor: 4.129

3.  Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial.

Authors:  Wei-Jei Lee; Po-Jui Yu; Weu Wang; Tai-Chi Chen; Po-Li Wei; Ming-Te Huang
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

4.  Bariatric surgery: Asia-Pacific perspective.

Authors:  Wei-Jei Lee; Weu Wang
Journal:  Obes Surg       Date:  2005 Jun-Jul       Impact factor: 4.129

5.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

Authors:  Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

6.  Laparoscopic versus open vertical banded gastroplasty for the treatment of morbid obesity.

Authors:  W J Lee; I R Lai; M T Huang; C C Wu; P L Wei
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2001-02       Impact factor: 1.719

7.  Weight gain as a risk factor for clinical diabetes mellitus in women.

Authors:  G A Colditz; W C Willett; A Rotnitzky; J E Manson
Journal:  Ann Intern Med       Date:  1995-04-01       Impact factor: 25.391

8.  The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism.

Authors:  Francesco Rubino; Michel Gagner; Paolo Gentileschi; Subhash Kini; Shoji Fukuyama; John Feng; Ed Diamond
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

9.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.

Authors: 
Journal:  Diabetes       Date:  1995-08       Impact factor: 9.461

View more
  8 in total

1.  ESR1, FTO, and UCP2 genes interact with bariatric surgery affecting weight loss and glycemic control in severely obese patients.

Authors:  Tsan-Hon Liou; Hsin-Hung Chen; Weu Wang; Shu-Fen Wu; Yi-Chih Lee; Wei-Shiung Yang; Wei-Jei Lee
Journal:  Obes Surg       Date:  2011-11       Impact factor: 4.129

2.  A Pilot Study: The Effect of Roux-en-Y Gastric Bypass on the Serum MicroRNAs of the Type 2 Diabetes Patient.

Authors:  Kuang Lirun; Mark Sewe; Wang Yong
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

3.  Outcome after gastrectomy in gastric cancer patients with type 2 diabetes.

Authors:  Jong Won Kim; Jae-Ho Cheong; Woo Jin Hyung; Seung-Ho Choi; Sung Hoon Noh
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

4.  Laparoscopic Roux-en-Y gastric bypass in obese Korean patients: efficacy and potential adverse events.

Authors:  Ji Yeon Park; Yong Jin Kim
Journal:  Surg Today       Date:  2015-04-26       Impact factor: 2.549

5.  Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial.

Authors:  Ralph Peterli; Robert E Steinert; Bettina Woelnerhanssen; Thomas Peters; Caroline Christoffel-Courtin; Markus Gass; Beatrice Kern; Markus von Fluee; Christoph Beglinger
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

6.  Role of microRNAs in the treatment of type 2 diabetes mellitus with Roux-en-Y gastric bypass.

Authors:  Z Zhu; J Yin; D C Li; Z Q Mao
Journal:  Braz J Med Biol Res       Date:  2017-03-02       Impact factor: 2.590

Review 7.  Revisional Surgeries of Laparoscopic Sleeve Gastrectomy.

Authors:  Siyuan Li; Siqi Jiao; Siwei Zhang; Jiangjiao Zhou
Journal:  Diabetes Metab Syndr Obes       Date:  2021-02-10       Impact factor: 3.168

Review 8.  Recent advancements in bariatric/metabolic surgery.

Authors:  Wei-Jei Lee; Owaid Almalki
Journal:  Ann Gastroenterol Surg       Date:  2017-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.